Families Sue Over Medicaid Gender-Affirming Care Rules
The lawsuit challenges a federal funding ban affecting Medicaid and CHIP coverage for transgender youth in New Hampshire.
Updated on Oct. 30, 2026 in Allergies

Four New Hampshire families are challenging a federal rule that prevents Medicaid and CHIP from funding gender-affirming care for transgender youth. The lawsuit argues that the policy, which took effect in October 2026, causes irreparable harm to families who rely on public health coverage.
Why it matters
The case highlights a significant shift in federal coverage for gender dysphoria treatment, placing many families at risk of losing access to ongoing medical support. The ruling will determine if the federal government has the authority to implement these specific coverage exclusions.
A federal rule took effect on October 13, 2026, barring Medicaid and CHIP funding for gender-affirming care, including medications like puberty blockers. The legal impact on youth access remains under investigation as the court considers a requested preliminary injunction.
The players
Trump administration
The federal executive authority responsible for implementing policies on Medicaid and CHIP funding eligibility.
Centers for Medicare & Medicaid Services
The federal agency that administers health coverage programs and is challenged in this lawsuit for its coverage exclusions.
The details
The rule restricts federal funding for treatments related to gender dysphoria, effectively removing these services from Medicaid and CHIP benefits. Plaintiffs argue this departure from past practice exceeds the regulatory authority of the Centers for Medicare & Medicaid Services. Meanwhile, the administration maintains that these medical procedures provide no proven benefits to young people and carry potential for irreversible physical consequences.
Timeline
New Hampshire banned gender-affirming care for new patients under 18 in 2025.
The federal rule restricting Medicaid coverage took effect on October 13, 2026.
An injunction decision is expected within the upcoming weeks.
A final resolution of the lawsuit is expected to take years.
Health Landscape
This litigation sits at the center of an evolving debate over the role of federal agencies in defining the scope of essential health benefits for transgender youth. It reflects an intensifying conflict between state-level bans and federal coverage standards.
Families relying on Medicaid or CHIP for gender-affirming care may face immediate coverage disruptions during this transition period. Anyone affected by these funding changes should consult their physician to explore alternative care pathways while the court reviews the request for an injunction.
The takeaway
This lawsuit underscores the uncertainty surrounding access to gender-affirming care for youth under public insurance programs. Families are encouraged to track the pending injunction decision for potential updates to their coverage eligibility.
Further reading
For more on evolving care standards, see our Allergies section.
Source note: This article includes information reported by Concord Monitor.





